Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
Outline of the case study analysis In order to examine how IAS 38 ”Intangible assets” is applied in practice by EU corporations, we surveyed the accounting treatment of internally generated development costs of fifty
Add to Reading List
Document Date: 2014-07-25 01:17:30
Open Document
File Size: 163,50 KB
Share Result on Facebook
Company
I. Industries /
GLAXOSMITHKLINE /
BAYER /
PERNOD RICARD /
AVENTIS /
NOVARTIS /
MERCK /
UNILEVER /
SYNGENTA /
CADBURY SCHWEPPES /
SANOFI /
HENKEL /
ORKLA /
DANISCO /
NESTLE /
ASTRAZENECA /
DANONE /
BASF /
/
Continent
Europe /
/
Country
Japan /
/
Currency
EUR /
/
Event
FDA Phase /
/
IndustryTerm
beverage industries /
pharmaceuticals /
pharmaceutical industry /
software /
chemical industry /
pharmaceutical development costs /
beverage industry /
pharmaceutical products /
food industry /
car manufacturers /
food /
/
Organization
European Union /
/
Product
IAS38 /
/
SocialTag
Financial accounting
Generally Accepted Accounting Principles
Intangible asset
Intellectual property law
Taxation
Income statement
Expense
Amortization
International Financial Reporting Standards
Accountancy